Cohen & Steers (CNS) Cash & Equivalents (2010 - 2026)

Cohen & Steers (CNS) has 17 years of Cash & Equivalents data on file, last reported at $53.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 18.6% year-over-year to $53.1 million; the trailing twelve-month figure through Mar 2026 stood at $53.1 million (down 18.6% YoY), and the FY2025 full-year result was $145.5 million, down 20.51% from the prior year.
• Cash & Equivalents fell to $53.1 million in Q1 2026, from $145.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $247.4 million in Q4 2022 to a low of $53.1 million in Q1 2026.
• A 5-year average of $131.6 million and a median of $126.6 million in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents soared 76.28% in 2023 and sank 34.46% in 2025, its largest moves.
• Tracing CNS's Cash & Equivalents over 5 years: stood at $247.4 million in 2022, then fell by 24.24% to $187.4 million in 2023, then slipped by 2.38% to $183.0 million in 2024, then declined by 20.51% to $145.5 million in 2025, then plunged by 63.5% to $53.1 million in 2026.
• Business Quant data shows CNS's Cash & Equivalents at $53.1 million in Q1 2026, $145.5 million in Q4 2025, and $98.1 million in Q3 2025.